What's Happening?
BUILT Biotechnologies, Inc. has announced the expansion of its DNA Manufacturing-as-a-Service capabilities, along with the onboarding of over 50 new customers. The company, headquartered in Charlottesville,
Virginia, is known for its Regenerative DNA Assembly platform, which provides high-fidelity DNA constructs for genome engineering. This expansion includes increased manufacturing capacity and the addition of experienced commercial leaders to support customer growth. BUILT's centralized DNA manufacturing model eliminates the need for in-house assembly, offering reliable and rapid delivery of complex DNA sequences to researchers and developers worldwide.
Why It's Important?
The expansion of BUILT Biotechnologies' DNA manufacturing capabilities is a significant development in the biotechnology industry, particularly for genome engineering and synthetic biology. By providing a reliable and efficient DNA supply chain, BUILT supports researchers in advancing their genome engineering programs, which can lead to breakthroughs in medicine, agriculture, and environmental science. The company's growth reflects the increasing demand for outsourced DNA production and the importance of supply chain resilience in the biotech sector. This expansion also highlights the role of innovative platforms in accelerating scientific research and development.
